Loading...
XNYS
MPT
Market cap2.77bUSD
Jul 09, Last price  
4.60USD
1D
2.68%
1Q
-6.88%
Jan 2017
-62.60%
IPO
-58.30%
Name

Medical Properties Trust Inc

Chart & Performance

D1W1MN
XNYS:MPT chart
P/E
—
P/S
2.85
EPS
—
Div Yield, %
7.17%
Shrs. gr., 5y
2.52%
Rev. gr., 5y
-4.89%
Revenues
972m
-2.36%
50,471,43281,786,000107,070,000114,038,000108,024,000132,322,000198,125,000242,523,000312,532,000441,878,000541,137,000704,745,000784,522,000870,248,0001,249,238,0001,544,669,0001,542,851,000871,799,000995,547,000972,022,000
Net income
-199m
L-91.76%
30,159,69841,240,00032,700,00036,330,00022,913,00026,536,00089,900,00096,991,00050,522,000139,598,000225,048,000289,793,0001,016,685,000374,684,000431,450,000656,021,000902,597,000-556,476,000-2,410,271,000-198,701,000
CFO
231m
-5.99%
42,083,34136,829,61769,917,00062,751,00060,637,00079,270,000105,309,000140,801,000150,443,000206,996,000264,683,000363,101,000449,088,000494,117,000617,636,000811,656,000739,010,000505,786,000245,483,000230,767,000
Dividend
Dec 11, 20250.09 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Established in 2003, Medical Properties Trust, Inc. (MPT) functions as a self-managed real estate investment trust (REIT), primarily focused on acquiring and developing hospital properties under net-lease arrangements. From its humble beginnings in Birmingham, Alabama, MPT has expanded significantly, becoming a leading global proprietor of hospital assets. Its extensive, pro forma portfolio now boasts 431 facilities, encompassing approximately 43,000 licensed beds across nine different countries and four continents. MPT's unique financing approach empowers hospital operators to undertake new acquisitions and recapitalize their holdings, effectively unlocking the capital within their real estate to finance critical facility enhancements, technological advancements, and other operational investments.
URL
https://medicalpropertiestrust.com/
IPO date
Jul 08, 2005
Employees
119
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT